Newamsterdam Pharma Company Nv (NAMS)

Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	21.74%3.70	3.04	0.03	0.35	19.15
	11.56%68.57	61.46	66.01	55.49	54.78
Selling, General, and Administrative	14.67%26.89	23.45	27.42	24.52	27.26
Research and Development	9.64%41.67	38.01	38.59	30.97	27.52
Depreciation and Amortization	35.04%0.09	0.14	0.13	0.13	0.11
Operating Income/Loss	11.03%-64.86	-58.42	-65.98	-55.14	-35.64
Income/Loss From Continuing Operations Before Tax	32.40%-64.14	-48.44	-74.92	-72.01	-17.36
	32.40%-64.14	-48.44	-74.92	-72.01	-17.36
Attributable To Parent	32.40%-64.14	-48.44	-74.92	-72.01	-17.36
Basic Average Shares	1.36%123.37	121.72	0.52	119.00	118.56
Diluted Average Shares	1.36%123.37	121.72	0.52	119.00	118.56
Basic Earnings Per Share	30.00%-0.52	-0.40	-0.63	-0.61	-0.15
Diluted Earnings Per Share	30.00%-0.52	-0.40	-0.63	-0.61	-0.15